Prikaz rezultata 1 – 6 od 6 za pretragu 'Lindi Chen (15053630)', vrijeme upita: 0,01s Detaljiziraj rezultate
  1. 1
    Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S6 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  2. 2
    Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  3. 3
    Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S5 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  4. 4
    Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  5. 5
    Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S4 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:
  6. 6
    Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

    Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models od Elizabeth R. Tucker (15053624)

    Izdano 2025
    Daljnji autori:
    Spremi u popis
    Spremljeno u:

Alati za pretragu: